| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.96B | +23.7% |
| R&D Expense | $245.8M | +30.2% |
| SG&A Expense | $144.3M | -12.7% |
| Operating Income | -$63.4M | +59.0% |
| Pre-tax Income | -$59.6M | +61.5% |
| Income Tax | -$1.1M | -120.0% |
| Net Income | -$58.5M | +62.1% |
| EPS (Basic) | -$0.10 | +67.7% |
| EPS (Diluted) | -$0.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.0M | -11.1% |
| Accounts Receivable | $57.0M | +17.3% |
| Current Assets | $317.2M | -3.9% |
| Total Assets | $1.54B | +30.7% |
| Current Liabilities | $367.3M | +4.0% |
| Total Liabilities | $752.2M | -1.8% |
| Stockholders' Equity | $782.0M | +91.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $216.7M | +78.4% |
| Capital Expenditures | $13.4M | -14.6% |
| Investing Cash Flow | -$191.3M | -422.7% |
| Financing Cash Flow | -$50.2M | -79.3% |
| Free Cash Flow | $203.3M | +92.2% |
| +67.7% |